Extend Biosciences Inc. SBIR Phase I Award, March 2020
A SBIR Phase I contract was awarded to Extend Biosciences in March, 2020 for $161,589.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.